|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Jan-Yau Hsu | HongRen Wang | ChiHsing Chang | 02-25158228 | 11F, 10 Minsheng E. Road, Sec. 3, Taipei 104 TaiwanTaipei, Taiwan | 2012/09/18 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | To be one of the most innovative and successful biopharmaceutical companies specializing for the treatment of cancer andAsian prevalent diseases. PharmaEngine, Inc. is a networed pharma company which adopts the “Virtual Pharmaceutical Company Business Model” for new drug development. We license in drug candidates ranging from preclinical to clinical stages and further develop the projects in niche markets. |
Market Information ( 2024/09/20 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
850.383 | 88.80 | 85.90 | 87.40 | 1.40 | 1044 | 6,055 | 4 | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/09/20) |
TPEx measures adopted (2024/09/20) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |